Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 520 and 522
[Docket No. FDA-2009-N-0270]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations by removing those portions that reflect approval of two new animal drug applications (NADAs) and an abbreviated new animal drug application (ANADA). In a notice published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is withdrawing approval of these NADAs and ANADA.
 DATES: This rule is effective August 3, 2009.
 FOR FURTHER INFORMATION CONTACT: John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, e-mail: 
                        *john.bartkowiak@fda.hhs.gov*.


SUPPLEMENTARY INFORMATION: The following sponsors have requested that FDA withdraw approval of the two NADAs and ANADA listed in table 1 of this document because the products are no longer manufactured or marketed: **Table 1.**
Sponsor
NADA/ANADA Number
                             Product (Drug)
21 CFR Cite Affected 
                             (Sponsor Drug Labeler Code)Wellmark International, 1501 East Woodfield Rd., suite 200, West Schaumburg, IL 60173
NADA 141-162
                             Zodiac Fleatrol Flea Caps (S-methoprene)
520.1390 (011536)IDEXX Pharmaceuticals, Inc., 7009 Albert Pick Rd., Greensboro, NC 27409
NADA 141-178
                             NAVIGATOR Paste (nitazoxanide)
520.1498 (065274)Abbott Laboratories, North Chicago, IL 60064
ANADA 200-279
                             KETAFLO Injection (ketamine HCl, USP)
522.1222a (000074)
 In a notice published elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADAs 141-162 and 141-178, and ANADA 200-279, and all supplements and amendments thereto, are withdrawn, effective August 3, 2009. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect the withdrawal of approval. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects in 21 CFR Parts 520 and 522 Animal drugs
 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 520 and 522 are amended as follows: PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
 1.The authority citation for 21 CFR part 520 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 520.1390
 2.Remove § 520.1390. § 520.1498
 3.Remove § 520.1498. PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
 4.The authority citation for 21 CFR part 522 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 522.1222a
 5.In paragraph (b) of § 522.1222a, remove “000074,”. Dated: July 14, 2009. Bernadette Dunham, Director, Center for Veterinary Medicine.


[FR Doc. E9-17409 Filed 7-21-09; 8:45 am] BILLING CODE 4160-01-S